George R Delaney, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 7500 212th St Sw, Suite 104, Edmonds, WA 98026 Phone: 425-582-9617 Fax: 425-582-9686 |
Richard Claude Phillips, MD, MS, MPH General Practice Medicare: Not Enrolled in Medicare Practice Location: 51 W Dayton St, Suite #305, Edmonds, WA 98020 Phone: 425-670-1560 Fax: 425-361-1512 |
Ella Yepraksia Bostanjian, M.D. General Practice Medicare: Accepting Medicare Assignments Practice Location: 617 5th Ave S, Edmonds, WA 98020 Phone: 425-697-2100 Fax: 425-697-5556 |
Dr. Jillian Nicole Warner, M.D. General Practice Medicare: Accepting Medicare Assignments Practice Location: 21601 76th Ave W, Edmonds, WA 98026 Phone: 425-640-4000 |
News Archive
In the Global Health Technologies Coalition's (GHTC) "Breakthroughs" blog, Ashley Bennett, senior policy associate at GHTC, "provides a summary of what the compromise means for the federal budget, and what might happen to global health and international development programs."
A recent article in the Centers for Disease Control and Prevention (CDC)'s Emerging Infectious Diseases reveals that the last of these was probably due to the introduction of a new variant from Nepal. This novel variant had been circulating in the community for about a month before the last outbreak was reported.
While a focus on HIV prevention and treatment among women and children has reduced infection rates among these populations, "men have received considerably less attention in the epidemic and receive less targeted HIV prevention and treatment programs," Edward Mills of the University of Ottawa and colleagues write in a PLoS Medicine essay, adding "Targeting men in prevention and treatment ... may have a large impact on mortality, new infections, and the economic impact of HIV/AIDS in Africa."
Rules-Based Medicine, Inc. (RBM) today announced the Cancer Prevention and Research Institute of Texas (CPRIT) has granted it a Company Commercialization Award to expand and enhance the OncologyMAP™ program for discovery and development of novel diagnostic and prognostic cancer tests. The award of approximately $3 million will fund research and development to more than double the number of cancer-associated biomarker assays in RBM's new OncologyMAP™ product.
A study by researchers at Mayo Clinic Cancer Center has found that cancer patients diagnosed with COVID-19 who received care at home via remote patient monitoring were significantly less likely to require hospitalization for their illness, compared to cancer patients with COVID-19 who did not participate in the program.
› Verified 9 days ago